Magnolol Potentiates Sorafenib-induced Apoptosis and Inhibits Metastatic Signaling in Renal Carcinoma
CHE-CHENG CHANG, M.-H. Hung, Yueh‐Shan Weng, CHIEH-MIN CHANG et autres
BACKGROUND/AIM: Sorafenib is a standard targeted therapy for renal cell carcinoma; however, resistance and limited efficacy remain clinical challenges. Magnolol, a bioactive compound derived from Magnolia officinalis, exhibits anti-cancer properties, and may enhance therapeutic responses. This study investigated whether magnolol potentiates the …
tw, kr (code pays fourni par la source)
0 citations
In Vivo